Biogen Inc (NASDAQ: BIIB) |
|
Biogen Inc Balance Sheets Quarterly
BIIB
Select the Financial Report: |
Period: |
|
|
BIIB Balance Sheets
(Quarterly, GAAP in millions $) |
(Sep 30 2022) Q3 |
(Jun 30 2022) Q1 |
(Mar 31 2022) Q1 |
(Dec 31 2021) Q4 |
(Sep 30 2021) Q3 |
ASSETS |
Cash & cash equivalent |
- |
- |
- |
- |
- |
Cash, Cash eqvivalents other |
- |
- |
- |
- |
- |
Available-for-sale Securities, Debt Securities, Current MA |
1,235.50 |
2,151.30 |
2,002.40 |
1,541.10 |
1,413.30 |
Cash
& Short-term Investments |
1,235.50 |
2,151.30 |
2,002.40 |
1,541.10 |
1,413.30 |
Accounts receivable |
1,568.80 |
1,567.60 |
1,632.00 |
1,549.40 |
1,723.00 |
Other receivables net |
- |
- |
- |
- |
- |
Net Receivables |
- |
- |
- |
- |
- |
Due From Unconsolidated Joint Business |
- |
- |
- |
412.30 |
- |
Inventories |
1,375.00 |
1,294.20 |
1,215.40 |
1,351.50 |
1,347.90 |
Other current assets |
5,586.50 |
4,727.80 |
3,066.10 |
3,414.50 |
2,678.10 |
Total Current Assets |
9,765.80 |
9,740.90 |
7,915.90 |
7,856.50 |
7,162.30 |
Equipment/Property/Plant Net |
3,266.40 |
3,355.10 |
3,372.80 |
3,416.40 |
3,410.70 |
Goodwill net |
5,741.20 |
5,749.60 |
5,758.00 |
5,761.10 |
5,760.50 |
Intangible Assets |
2,008.90 |
2,075.30 |
2,150.80 |
2,221.30 |
2,286.80 |
Long-term investments |
860.30 |
1,102.90 |
1,001.60 |
892.00 |
968.30 |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Restricted cash |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net, Noncurrent AS |
- |
- |
- |
- |
- |
Other Assets |
2,790.00 |
2,739.00 |
3,059.00 |
3,356.00 |
3,831.00 |
Assets held for sale |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Operating Lease Right Of Use Asset |
424.50 |
321.10 |
359.00 |
375.40 |
389.10 |
Total Assets |
24,854.20 |
25,081.40 |
23,614.40 |
23,877.30 |
23,806.70 |
LIABILITIES |
Accounts Payable, Current AC |
383.20 |
434.80 |
398.70 |
589.20 |
427.90 |
Accrued liabilities |
- |
- |
- |
- |
- |
Restructuring liabilities |
- |
- |
- |
- |
- |
Notes Payable, Current NO |
- |
999.80 |
999.50 |
999.10 |
998.80 |
Other current liabilities |
3,305.90 |
3,298.50 |
2,231.10 |
2,535.20 |
2,550.70 |
Taxes Payable, Current, Total |
237.30 |
284.90 |
317.30 |
174.70 |
234.20 |
Interest |
- |
- |
- |
- |
- |
Customer deposits |
- |
- |
- |
- |
- |
Total Current Liabilities |
3,926.40 |
5,018.00 |
3,946.60 |
4,298.20 |
4,211.60 |
Long-term debt |
6,279.20 |
6,277.40 |
6,275.70 |
6,274.00 |
6,272.30 |
Capital lease obligations |
- |
- |
- |
- |
- |
Long-term debt Convertible |
- |
- |
- |
- |
- |
Total
Long-term Debt |
6,279.20 |
6,277.40 |
6,275.70 |
6,274.00 |
6,272.30 |
Other Preferred stock |
- |
- |
- |
- |
- |
Employee benefit plans |
- |
- |
- |
- |
- |
Deferred rent |
- |
- |
- |
- |
- |
Deferred Tax Liabilities, Net, Noncurrent LI |
- |
- |
- |
- |
- |
Disposal Group, Including Discontinued Operation, Other Liabilities |
- |
- |
- |
- |
- |
Other longterm liabilities |
1,881.80 |
1,922.60 |
2,171.40 |
2,345.40 |
2,441.10 |
Operating Lease Liability Noncurrent |
354.80 |
274.20 |
312.30 |
330.40 |
348.20 |
Total Liabilities |
12,087.40 |
13,218.00 |
12,393.70 |
12,917.60 |
12,925.00 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
0.10 |
0.10 |
0.10 |
0.10 |
0.10 |
Treasury Stock Value |
-2,977.10 |
-2,977.10 |
-2,977.10 |
-2,977.10 |
-2,977.10 |
Additional Paid In Capital Common Stock |
- |
- |
119.00 |
68.20 |
- |
Retained Earnings / Accumulated Deficit |
15,916.10 |
14,959.90 |
14,215.50 |
13,911.70 |
13,543.50 |
Other Equity |
-163.60 |
-110.40 |
-115.20 |
-106.70 |
-136.60 |
Noncontrolling interests & other |
-8.70 |
-9.10 |
-21.60 |
63.50 |
451.80 |
Total
Stockholder's Equity |
12,766.80 |
11,863.40 |
11,220.70 |
10,959.70 |
10,881.70 |
Liabilities & Stockholder's
Equity |
24,854.20 |
25,081.40 |
23,614.40 |
23,877.30 |
23,806.70 |
|